Safety Concerns Remain Over Three-Person IVF
By Ted Morrow,
The Guardian
| 07. 22. 2014
Untitled Document
Later this year, parliament is expected to debate a change to the law that would allow a reproductive therapy called mitochondrial replacement (MR) into fertility clinics. A recent review of evidence by the UK fertility regulator, the Human Fertilisation and Embryology Authority, stated that this experimental technique is "not unsafe". But while the aim of the procedure is noble – to eliminate human mitochondrial diseases, which affect around 1 in 4,000 people – a number of important safety concerns remain unresolved.
Evolutionary theory predicts a mismatch between the DNA in the donor's mitochondria and the mother's nuclear DNA, with potentially serious and unpredictable consequences for any embryo created using MR, an issue my colleagues and I wrote about last year. When MR is carried out experimentally, it has been shown to alter the metabolism and cognitive ability of mice. In other species it results in male sterility, reduced survival, accelerated ageing and changes the expression of many hundreds of genes. But there is a lack of data from species more closely related to humans...
Related Articles
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Gabriele Pichlhofer and Tino Plümecke, Guest Contributors
| 03.25.2026
A German translation of this interview will be published in May 2026 in the German GID MAGAZIN, which focuses on the market for reproductive technologies. For more information, visit: Gen-ethisches Netzwerk
Egg donation is currently prohibited in Germany and Switzerland, but both countries have been debating its legalization for years. In Switzerland, a legal framework is currently being developed, with a first draft expected by the end of the year. Yet the debate rarely draws on scientific evidence. Instead...
By Charles Pulliam-Moore, The Verge | 03.21.2026
Like many people, director Valerie Veatch was intrigued when OpenAI first released its Sora text-to-video generative AI model to the public in 2024. Though she didn’t fully understand the technology, she was curious about what it could do, and she...
By Ritsuko Kawai, Wired | 03.14.2026
On March 6, Japan’s Ministry of Health, Labor and Welfare officially granted conditional and time-limited marketing authorization to two regenerative medical products derived from reprogrammed iPS cells, marking exactly 20 years since the creation of mouse iPS cells.These will...